NEW YORK (TheStreet) -- InterOil (IOC) fell sharply on Friday after shares resumed trading following its announcement it would sell a 61.3% stake in its Papua New Guinean natural-gas fields to Total SA (TOT).
Total's acquisition, worth as much as $3.6 billion, will address development and expansion of the Elk-Antelope site's reserves with payment pending appraisal drilling and certification. The French oiler will pay $613 million upfront. Additional payments will be made upon completion of its appraisal and whether its estimates of between 5.4 trillion and 9 trillion cubic feet of gas can be farmed.
Investors fled the stock en masse triggering a waterfall of selling once trading resumed in the afternoon. The accepted cause was that a maximum $3.6 billion valuation was seen as too little for the undeveloped Elk-Antelope site, believed to potentially hold the largest natural-gas depository in Asia. Until a full valuation can be determined by 2016, investors who stick with the stock will stomach more than a year's uncertainty over exactly how much InterOil will benefit.
Top 5 Performing Companies To Buy For 2015: Invacare Corporation (IVC)
Invacare Corporation designs, manufactures, and distributes medical equipment and supplies for non-acute care environment, including the home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, including power wheelchairs, custom manual wheelchairs, personal mobility products, and seating and positioning products; lifestyle products, such as manual wheelchairs, personal care products, homecare beds, pressure relieving mattresses, and patient transport products; and respiratory therapy products comprising non-delivery oxygen, stationary oxygen concentrators, and aerosol products and oxygen accessories. It also provides assistance in the collection of outstanding co-pays, rental capabilities, software, and technology to streamline efficiencies, repair services, and replacement parts. In addition, the company distributes medical supplies, including ostomy, incontinence, diabetic, enteral, wound care, and urology products , as well as home medical equipment, including lifestyle products. Further, it manufactures and markets healthcare furnishings comprising beds, case goods, and patient handling equipment for the long-term care markets; specialty clinical recliners for dialysis and oncology clinics; and other home medical equipment and accessory products. Additionally, the company offers home medical equipment for rent. It serves home health care and medical equipment providers, distributors, and government locations through its sales force, telesales associates, and various organizations of independent manufacturers� representatives and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.
Advisors' Opinion:- [By Roberto Pedone]
Invacare (IVC) designs, manufactures and distributes a line of health care products for the non-acute care environment, including the home health care, retail and extended care markets. This stock closed up 2.3% at $16.73 in Monday's trading session.
Monday's Volume: 218,000
Three-Month Average Volume: 143,188
Volume % Change: 75%From a technical perspective, IVC jumped higher here right above some near-term support at $16 with above-average volume. This move briefly pushed shares of IVC into breakout territory, since the stock flirted with some past resistance at $16.81. This move is also close to pushing shares of IVC above the upper-end of its recent sideways trading price action, that has seen IVC trade between $14.92 on the downside and $16.81 on the upside.
Traders should now look for long-biased trades in IVC as long as it's trending above its 50-day at $15.75 and then once it sustains a move or close above Monday's high of $16.84 with volume that's near or above 143,188 shares. If we get that move soon, then IVC will set up to re-test or possibly take out its next major overhead resistance levels at $18.24 to $19.15.
Top 10 Managed Healthcare Stocks For 2014: Nektar Therapeutics(NKTR)
Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. The company?s product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology. Its research and development activities involve small molecule drugs, peptides, and other potential biologic drug candidates. The company?s proprietary drug candidates in clinical development comprise NKTR-118, a peripheral opioid antagonist, which has completed Phase II clinical trail for the treatment of opioid-induced constipation; BAY41-6551 that has completed Phase II clinical trail to treat gram-negative pneumonias; NKTR-102, a topoisomerase I inhibitor-polymer conjugate, which is in Phase II clinical trail for multiple cancer indications, including breast, ovarian, and colorectal; and NKTR-105 that is in Phase I clinica l trail to treat solid tumors. Its preclinical products consists of NKTR-119 (Opioid/NKTR-118 combinations) for the treatment of pain; NKTR-181 (abuse deterrent, tamper-resistant opioid) to treat pain; NKTR-194 (non-scheduled opioid) for the treatment of mild to moderate pain; NKTR-171 (tricyclic antidepressant) to treat neuropathic pain; and NKTR-140 (protease inhibitor candidate) to treat HIV. The company has collaboration with Bayer Healthcare LLC to develop BAY41-6551 (NKTR-061, Amikacin Inhale), which is an inhaled solution of amikacin, an aminoglycoside antibiotic; and a license agreement with AstraZeneca AB for the development and commercialization of Oral NKTR-118 and NKTR-119. In addition, Nektar Therapeutics has various license, manufacturing, and supply agreements for its technology with biotechnology and pharmaceutical companies, such as Affymax, Amgen, Baxter, Roche, Merck, Pfizer, and UCB Pharma. The company was founded in 1990 and is headquartered in San Franc isco, California.
Advisors' Opinion:- [By Jay Silverman]
Steve Halpern: Another stock you follow closely is Nektar (NKTR). What do you see happening there?
Jay Silverman: Yes, Nektar is another platform company at the MTSL and they are about to release data on one of their compounds that is a pain reliever-unlike the very severe side effects of OxyContin, the opioid pain relievers that are out there, which have caused severe health and addictive concerns, leading to very, very troublesome side effects and death in some cases.
- [By Sean Williams]
Nektar Therapeutics (NASDAQ: NKTR ) delivered a double-digit gain for shareholders this week after reporting positive top-line data for NKTR-181, its oral chronic pain-treatment drug. NKTR-181 is an opioid-based compound that's designed to enter the brain slower than traditional opiates like oxycodone without sacrificing effectiveness and ultimately reducing addiction-like qualities to the medication. In trials, the data demonstrated that NKTR-181 had a statistically significant lower "drug liking" and "feeling high" score than oxycodone. While I'd certainly exercise caution in getting too excited, as the Food and Drug Administration is very harsh with regard to its regulation of opioid-based drugs, it's nonetheless good news for Nektar.
Top 10 Managed Healthcare Stocks For 2014: BankFinancial Corporation(BFIN)
BankFinancial Corporation operates as the holding company for BankFinancial, F.S.B., which provides commercial, family, and personal banking services in Illinois. It accepts deposit accounts, such as savings accounts, NOW accounts, checking accounts, money market accounts, certificates of deposit, and IRAs and other qualified plan accounts. The company?s loan portfolio consists of investment and business loans, including multi-family, nonresidential real estate, commercial, construction and land loans, and commercial leases, as well as one-to-four family residential mortgage loans comprising home equity loans, lines of credit, and other second mortgage loans. It also provides financial products and services consisting of cash management, funds transfers, bill payment and other online banking transactions, automated teller machines, safe deposit boxes, wealth management, and general insurance agency services. In addition, the company offers investment, financial planning, and other wealth management services; and sells life insurance, fixed annuities, property and casualty insurance, and other insurance products on an agency basis. It provides its products and services through banking offices and an Internet Branch. As of December 31, 2009, it operated 18 full-service banking offices and 3 express branch facilities in Cook, DuPage, Lake, and Will Counties, Illinois. The company was founded in 1924 and is headquartered in Burr Ridge, Illinois.
Advisors' Opinion:- [By Tim Melvin]
Thompson says the firm likes Bank Financial (BFIN) right now. The bank is in the lucrative Chicago market that has seen a lot of consolidation in the past year. The bank has 20 branches in fairly desirable locations and must be on the target list of anyone looking to expand into Chicago.
Top 10 Managed Healthcare Stocks For 2014: Point.360(PTSX)
Point.360 operates as an integrated media management services company in the United States. It offers film, video and audio post-production, archival, duplication, computer graphics, and data distribution services. The company also provides services to edit, master, reformat, covert, archive, and distribute its clients? film and video content, including television programming, feature films, and movie trailers. Its value-added services comprise visual effects, video and data editing, graphics and animation, digital color correction, picture restoration, audio post-production, audio restoration and layback, closed captioning and subtitling, foreign language mastering, standards conversion, broadcast encoding, global distribution and syndication, and archival services. In addition, Point.360 is involved in the rental and sale of DVDs and video games to consumers through its Movie>Q retail stores. Its customers include independent motion picture and television production com panies, television program suppliers, national television networks, infomercial providers, local television stations, television program syndicators, corporations, and educational institutions, as well as advertising agencies, and corporate or instructional video providers. The company is based in Burbank, California.
Advisors' Opinion:- [By Lisa Levin]
Point.360 (NASDAQ: PTSX) shares reached a new 52-week low of $0.528. Point.360's trailing-twelve-month ROE is -12.69%.
QC Holdings (NASDAQ: QCCO) shares tumbled 3.68% to reach a new 52-week low of $1.83. QC Holdings shares have dropped 42.60% over the past 52 weeks, while the S&P 500 index has gained 31.67% in the same period.
Top 10 Managed Healthcare Stocks For 2014: Saia Inc.(SAIA)
Saia, Inc., an asset-based trucking company, provides transportation and supply chain solutions primarily to the retail, chemical, and manufacturing industries in the United States. The company, through it subsidiary, Saia Motor Freight Line, LLC, offers regional and interregional less than truckload (LTL) services, selected national LTL, and time-definite services. It was formerly known as SCS Transportation, Inc. Saia, Inc. was founded in 2000 and is headquartered in Johns Creek, Georgia.
Advisors' Opinion:- [By Ben Levisohn]
Wunderlich’s Nicholas Bender thinks FedEx’s results bode well for Old Dominion (ODFL), Con-way (CNW) and Saia (SAIA):
We expect all less-than-truckload carriers to benefit in 2Q14 from the same trends that carried FedEx Freight to a banner 4Q14. This includes Hold-rated Old Dominion, which will continue to grow at well above market rates, and Buy-rated Con-way, which we believe can leverage a strong 2Q14 to prime the pump on margin enhancement efforts. Our favorite name in the space remains Saia (SAIA-$42.92, Buy), which will once again see accelerating tonnage growth in 2Q14. Though tonnage growth will moderate in� 2H14 due to steeper comps, there remains considerable potential for the company to boost yield and continue winning incremental business with new accounts.
- [By John Udovich]
Despite what can best be described as a�soft economy, small cap trucking stocks YRC Worldwide, Inc (NASDAQ: YRCW), Arkansas Best Corporation (NASDAQ: ABFS), Frozen Food Express Industries, Inc (NASDAQ: FFEX), Saia Inc (NASDAQ: SAIA) and USA Truck, Inc (NASDAQ: USAK) have been trucking some pretty impressive returns since the start of the year. In fact, these small cap trucking stocks are up anywhere from 72% to 150% or so since the start of the year despite the slow economy. Certainly trucking stocks provide a good indicator of how the economy is doing, but might investors be�jumping the gun by pushing up these trucking stocks?
Top 10 Managed Healthcare Stocks For 2014: Guggenheim CurrencyShares Japanese Yen Trust (FXY)
Guggenheim CurrencyShares Japanese Yen Trust, formerly CurrencyShares Japanese Yen Trust, is a grantor trust. The Trust issues shares (the Shares) in blocks of 50,000 (a Basket) in exchange for deposits of Japanese Yen and distributes Japanese Yen in connection with the redemption of Baskets. The investment objective of the Trust is for the Shares to reflect the price of Japanese Yen plus accrued interest, if any, less the expenses of the Trust�� operations. The Trust holds Japanese Yen and, from time to time, issues Baskets in exchange for deposits of Japanese Yen and distributes Japanese Yen in connection with redemptions of Baskets. The Sponsor of the Trust is Guggenheim Specialized Products, LLC, a Delaware limited liability company.
The Bank of New York Mellon, a banking corporation with trust powers organized under the laws of the State of New York, serves as the Trustee. The Shares are backed by the assets of the Trust, which does not hold or use derivative products.
Advisors' Opinion:- [By Matthew McCall]
The Rydex CurrencyShares Japanese Yen ETF (NYSE: FXY) has since fallen by nearly 30 percent since hitting a high during the fourth quarter of 2011.
- [By Ben Levisohn]
The euro has dropped about 0.8% against the dollar, while the CurrencyShares Euro Trust ETF (FXE) has dropped 0.7% to $136.71 and the Currency Shares Japanese Yen Trust ETF (FXY) has fallen 1%. The ProShares UltrasShort Euro ETF (EUO) has gained 1.3% to $16.77, while the ProShares UltraShort Yen (YCS) has gained 1.9% to $66.58.
Top 10 Managed Healthcare Stocks For 2014: PowerShares DB US Dollar Index Bullish Fund (UUP)
PowerShares DB US Dollar Index Bullish Fund (the Fund) is a separate series of PowerShares DB US Dollar Index Trust (the Trust). The Fund�� subsidiary is DB US Dollar Index Bullish Master Fund (the Master Fund), a separate series of DB US Dollar Index Bullish Master Trust (the Master Trust). The Fund offers common units of beneficial interest (the Shares) only to certain eligible financial institutions (the Authorized Participants) in one or more blocks of 200,000 Shares, called a Basket. The proceeds from the offering of Shares are invested in the Master Fund.
The Master Fund invests in futures contracts (the DX Contracts) with a view to tracking the changes, whether positive or negative, in the level of the Deutsche Bank US Dollar Index (USDX) Futures Index - Excess Return (Long Index) (referred to as the Long Index or the Index), over time. The Fund earns interest income from the United States Treasury obligations and other high credit quality short-term, fixed-income securities. The Index is calculated to reflect the changes in market value over time, whether positive or negative, of long positions in DX Contracts. DX Contracts are traded through the currency markets of ICE Futures U.S. under the symbol DX. The changes in market value over time, whether positive or negative, of the DX Contracts are related to the changes, whether positive or negative, in the level of the U.S. Dollar Index (the USDX). The Index provides a general indication of the international value of the United States dollar relative to the six major world currencies (the Index Currencies), which comprise the USDX, including Euro, Japanese Yen, British Pound, Canadian Dollar, Swedish Krona and Swiss Franc.
The Fund, through its Master Fund, establishes long positions in DX Contracts with a view to tracking the changes, whether positive or negative, in the level of the Index. The performance of the Fund also is intended to reflect the excess, if any, of its Master Fund�� interest income from its hol! dings of the United States Treasury obligations and other high credit quality short-term, fixed-income securities over the expenses of the Fund and the Master Fund. DB Commodity Services LLC serves as the managing owner, commodity pool operator and commodity trading advisor of the Fund and the Master Fund. DB Commodity Services LLC is an indirect wholly owned subsidiary of Deutsche Bank AG. The Bank of New York Mellon serves as the administrator of the Fund and the Master Fund.
Advisors' Opinion:- [By Luke Jacobi]
The US dollar once again tanked on the expectation that the Federal Reserve will not reduce its stimulus. The PowerShares ETF (NYSE: UUP) that tracks the performance of the greenback versus a basket of foreign currencies fell 0.02 percent to 21.39.
- [By Luke Jacobi]
Currencies
The US dollar once again tanked on the expectation that the Federal Reserve will not reduce its stimulus. The PowerShares ETF (NYSE: UUP) that tracks the performance of the greenback versus a basket of foreign currencies fell 0.56 percent to 21.35. The marks a year low for the dollar.
No comments:
Post a Comment